CLINICAL_TRIALS
trial_result
· 2017-02-24
Clinical Trial Update: Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer [Phase 4]
Summary
Phase 4 clinical trial evaluating dalteparin for long-term one-year treatment of blood clots in cancer patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Cancer | Phase 4 | Status: COMPLETED | Results posted: 2017-02-24